Surrey researchers Sign in
SIMVASTATIN DECREASES THE HEPATIC SECRETION OF VERY-LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN B-100 IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - PATHOPHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS
Journal article   Peer reviewed

SIMVASTATIN DECREASES THE HEPATIC SECRETION OF VERY-LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN B-100 IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - PATHOPHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS

GF WATTS, MH CUMMINGS, M UMPLEBY, J QUINEY, R NAOUMOVA, GR THOMPSON and PH SONKSEN
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, Vol.25(8), pp.559-567
01/08/1995

Abstract

Science & Technology Life Sciences & Biomedicine Medicine General & Internal Medicine Research & Experimental General & Internal Medicine Research & Experimental Medicine MEDICINE GENERAL & INTERNAL MEDICINE RESEARCH & EXPERIMENTAL B-CONTAINING LIPOPROTEINS CHOLESTERYL ESTER COMBINED HYPERLIPIDEMIA LOVASTATIN THERAPY STABLE ISOTOPES HEPG2 CELLS ACYL-COA METABOLISM PLASMA HEPATOCYTES
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RP24900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Details

Usage Policy